Portugal

Portugal

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.45 (0.90 - 0.20) 2016 Survey/reported Carvalhana SC , 2016
0.6 (0.10 - 1.60) 2014 Survey/reported Rocha, 2017
0.89 (0.58 - 1.35) 2015 Modelled WHO
1.2 (0.90 - 1.50) 2016 Modelled Razavi-Shearer et al, 2018
1.5 (0.90 - 2) 2014 Survey/reported ECDC
1.02 (0.78 - 1.31) 2013 Modelled Schweitzer et al, 2015
0.91 (0.74 - 1.09) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1 (0.82 - 1.18) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.82 - 1.21) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.85 - 1.21) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.06 (0.86 - 1.24) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.87 - 1.25) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.09 (0.90 - 1.27) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.11 (0.91 - 1.29) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.12 (0.93 - 1.32) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.14 (0.95 - 1.34) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.15 (0.96 - 1.34) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.16 (0.97 - 1.35) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.17 (0.97 - 1.35) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.18 (0.98 - 1.37) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.19 (0.98 - 1.38) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.21 (0.99 - 1.40) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.23 (1.01 - 1.44) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.25 (1.04 - 1.47) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.27 (1.05 - 1.51) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.28 (1.05 - 1.54) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.29 (1.07 - 1.54) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.3 (1.08 - 1.53) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.3 (1.07 - 1.53) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.31 (1.07 - 1.54) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.31 (1.07 - 1.54) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.32 (1.08 - 1.55) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.33 (1.08 - 1.56) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.34 (1.09 - 1.58) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.36 (1.10 - 1.61) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.37 (1.12 - 1.64) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.79 - 1.17) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.1 (0.05 - 0.17) 2015 Modelled WHO
0.04 (0.02 - 0.05) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.06 (0.04 - 0.08) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.09) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.09) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.09) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.04 - 0.09) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.10) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.10) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.10) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.05 - 0.11) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.05 - 0.11) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.06 - 0.12) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.06 - 0.12) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.06 - 0.12) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.06 - 0.13) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.07 - 0.15) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.14 (0.10 - 0.20) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.19 (0.13 - 0.27) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.24 (0.16 - 0.35) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.3 (0.19 - 0.44) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.37 (0.24 - 0.54) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.30 - 0.66) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.36 - 0.79) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.43 - 0.91) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.48 - 0.99) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.52 - 1.05) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.55 - 1.10) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.58 - 1.15) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.61 - 1.18) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.62 - 1.20) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.02 - 0.03) 2020 Modelled WHO
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
3.1 2017 Survey/reported ECDC
2.22 2010 Survey/reported EMCDDA
3.39 2009 Survey/reported EMCDDA
6.1 2008 Survey/reported EMCDDA
6.9 2007 Survey/reported EMCDDA
5.62 2006 Survey/reported EMCDDA
7.47 2005 Survey/reported EMCDDA
7.45 2004 Survey/reported EMCDDA
7.88 2003 Survey/reported EMCDDA
9.7 2002 Survey/reported EMCDDA
9.4 2001 Survey/reported EMCDDA
13.5 2000 Survey/reported EMCDDA
2 2016 Survey/reported EMCDDA
7 2015 Survey/reported EMCDDA
5.15 2014 Survey/reported EMCDDA
6.52 2013 Survey/reported EMCDDA
4.9 2012 Survey/reported EMCDDA
4.3 2011 Survey/reported EMCDDA
6.8 2010 Survey/reported EMCDDA
2.86 2009 Survey/reported EMCDDA
3.3 2008 Survey/reported EMCDDA
3.2 2007 Survey/reported EMCDDA
3 2006 Survey/reported EMCDDA
3.3 2005 Survey/reported EMCDDA
4.85 2004 Survey/reported EMCDDA
1.97 2009 Survey/reported EMCDDA
2.7 2008 Survey/reported EMCDDA
2.94 2007 Survey/reported EMCDDA
2.88 2006 Survey/reported EMCDDA
1.8 2005 Survey/reported EMCDDA
2.64 2004 Survey/reported EMCDDA
3.06 2003 Survey/reported EMCDDA
7.68 2002 Survey/reported EMCDDA
5.42 2001 Survey/reported EMCDDA
9.64 2000 Survey/reported EMCDDA
Showing out of
Show more
Prisoners
Download
Value (%) Year Type Source
10.8 (8.10 - 14) 2008 Survey/reported Marques NM et al, 2011
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
125,000 (91,000 - 160,000) 2016 Modelled Razavi-Shearer et al, 2018
96,485 (78,360 - 116,117) 2019 Modelled IHME, GBD 2019 (accessed 2020)
98,688 (80,275 - 118,535) 2019 Modelled IHME, GBD 2019 (accessed 2022)
102,078 (83,296 - 120,225) 2018 Modelled IHME, GBD 2019 (accessed 2022)
104,277 (83,749 - 123,334) 2017 Modelled IHME, GBD 2019 (accessed 2022)
106,013 (86,446 - 123,614) 2016 Modelled IHME, GBD 2019 (accessed 2022)
107,910 (87,644 - 126,567) 2015 Modelled IHME, GBD 2019 (accessed 2022)
109,583 (89,344 - 127,872) 2014 Modelled IHME, GBD 2019 (accessed 2022)
111,404 (91,825 - 129,895) 2013 Modelled IHME, GBD 2019 (accessed 2022)
113,218 (93,516 - 132,385) 2012 Modelled IHME, GBD 2019 (accessed 2022)
114,854 (95,520 - 135,060) 2011 Modelled IHME, GBD 2019 (accessed 2022)
116,146 (97,152 - 137,136) 2010 Modelled IHME, GBD 2019 (accessed 2022)
117,167 (98,233 - 137,175) 2009 Modelled IHME, GBD 2019 (accessed 2022)
118,128 (98,736 - 137,626) 2008 Modelled IHME, GBD 2019 (accessed 2022)
119,061 (99,109 - 138,377) 2007 Modelled IHME, GBD 2019 (accessed 2022)
119,996 (99,304 - 139,183) 2006 Modelled IHME, GBD 2019 (accessed 2022)
120,984 (99,313 - 140,458) 2005 Modelled IHME, GBD 2019 (accessed 2022)
122,333 (100,941 - 142,184) 2004 Modelled IHME, GBD 2019 (accessed 2022)
124,090 (102,686 - 144,970) 2003 Modelled IHME, GBD 2019 (accessed 2022)
125,857 (104,382 - 148,132) 2002 Modelled IHME, GBD 2019 (accessed 2022)
127,227 (105,573 - 151,172) 2001 Modelled IHME, GBD 2019 (accessed 2022)
127,815 (104,712 - 153,294) 2000 Modelled IHME, GBD 2019 (accessed 2022)
127,860 (105,908 - 152,240) 1999 Modelled IHME, GBD 2019 (accessed 2022)
127,839 (105,917 - 151,061) 1998 Modelled IHME, GBD 2019 (accessed 2022)
127,729 (105,396 - 150,344) 1997 Modelled IHME, GBD 2019 (accessed 2022)
127,546 (104,548 - 149,693) 1996 Modelled IHME, GBD 2019 (accessed 2022)
127,296 (104,102 - 149,242) 1995 Modelled IHME, GBD 2019 (accessed 2022)
127,249 (103,325 - 149,476) 1994 Modelled IHME, GBD 2019 (accessed 2022)
127,673 (103,080 - 150,120) 1993 Modelled IHME, GBD 2019 (accessed 2022)
128,477 (104,256 - 151,765) 1992 Modelled IHME, GBD 2019 (accessed 2022)
129,588 (104,494 - 153,491) 1991 Modelled IHME, GBD 2019 (accessed 2022)
130,941 (106,121 - 156,136) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.42 (1.87 - 3.13) 2019 Modelled IHME, GBD 2019 (accessed 2020)
4.38 (3.17 - 5.85) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4.47 (3.26 - 5.97) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.48 (3.29 - 5.95) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.48 (3.32 - 5.93) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.29 (3.17 - 5.69) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.32 (3.22 - 5.64) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.36 (3.29 - 5.65) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.18 (3.17 - 5.46) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.27 (3.22 - 5.55) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.9 (2.95 - 5.11) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.05 (3.07 - 5.29) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.66 (2.77 - 4.82) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.8 (2.88 - 5) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.56 (2.69 - 4.69) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.39 (2.58 - 4.44) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.29 (2.50 - 4.30) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.14 (2.39 - 4.08) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.98 (2.27 - 3.84) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.79 (2.13 - 3.64) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.66 (2.04 - 3.44) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (1.98 - 3.33) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.51 (1.93 - 3.25) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.46 (1.89 - 3.15) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.36 (1.82 - 3.04) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.41 (1.86 - 3.09) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.33 (1.78 - 2.99) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.38 (1.83 - 3.07) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.41 (1.84 - 3.10) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.41 (1.85 - 3.09) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.42 (1.87 - 3.13) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
587 2016 Modelled WHO
444 (321 - 593) 1990 Modelled IHME, GBD 2019 (accessed 2022)
454 (331 - 605) 1991 Modelled IHME, GBD 2019 (accessed 2022)
455 (334 - 604) 1992 Modelled IHME, GBD 2019 (accessed 2022)
456 (338 - 604) 1993 Modelled IHME, GBD 2019 (accessed 2022)
438 (323 - 582) 1994 Modelled IHME, GBD 2019 (accessed 2022)
443 (331 - 579) 1995 Modelled IHME, GBD 2019 (accessed 2022)
449 (339 - 583) 1996 Modelled IHME, GBD 2019 (accessed 2022)
442 (333 - 575) 1997 Modelled IHME, GBD 2019 (accessed 2022)
435 (330 - 569) 1998 Modelled IHME, GBD 2019 (accessed 2022)
425 (322 - 555) 1999 Modelled IHME, GBD 2019 (accessed 2022)
411 (311 - 539) 2000 Modelled IHME, GBD 2019 (accessed 2022)
389 (295 - 514) 2002 Modelled IHME, GBD 2019 (accessed 2022)
403 (305 - 530) 2001 Modelled IHME, GBD 2019 (accessed 2022)
380 (288 - 501) 2003 Modelled IHME, GBD 2019 (accessed 2022)
363 (276 - 475) 2004 Modelled IHME, GBD 2019 (accessed 2022)
321 (245 - 414) 2007 Modelled IHME, GBD 2019 (accessed 2022)
338 (257 - 438) 2006 Modelled IHME, GBD 2019 (accessed 2022)
353 (268 - 461) 2005 Modelled IHME, GBD 2019 (accessed 2022)
301 (230 - 393) 2008 Modelled IHME, GBD 2019 (accessed 2022)
287 (220 - 371) 2009 Modelled IHME, GBD 2019 (accessed 2022)
277 (213 - 359) 2010 Modelled IHME, GBD 2019 (accessed 2022)
271 (209 - 351) 2011 Modelled IHME, GBD 2019 (accessed 2022)
265 (204 - 340) 2012 Modelled IHME, GBD 2019 (accessed 2022)
260 (201 - 333) 2013 Modelled IHME, GBD 2019 (accessed 2022)
254 (195 - 327) 2014 Modelled IHME, GBD 2019 (accessed 2022)
250 (192 - 321) 2015 Modelled IHME, GBD 2019 (accessed 2022)
256 (196 - 329) 2016 Modelled IHME, GBD 2019 (accessed 2022)
258 (197 - 332) 2017 Modelled IHME, GBD 2019 (accessed 2022)
257 (197 - 330) 2018 Modelled IHME, GBD 2019 (accessed 2022)
258 (199 - 333) 2019 Modelled IHME, GBD 2019 (accessed 2022)
258 (199 - 333) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
4 (2 - 5) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1992 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 1998 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 1999 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2003 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2004 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 12) 2005 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2006 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2008 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2009 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2010 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 15) 2011 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2012 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2013 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2015 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2016 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2014 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2017 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 16) 2018 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 16) 2019 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
97 2019 Survey/reported WHO/UNICEF
97 2018 Survey/reported WHO/UNICEF
97 2017 Survey/reported WHO/UNICEF
97 2016 Survey/reported WHO/UNICEF
97 2015 Survey/reported WHO/UNICEF
98 2014 Survey/reported WHO/UNICEF
98 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
97 2011 Survey/reported WHO/UNICEF
96 2010 Survey/reported WHO/UNICEF
95 2009 Survey/reported WHO/UNICEF
95 2008 Survey/reported WHO/UNICEF
95 2007 Survey/reported WHO/UNICEF
91 2006 Survey/reported WHO/UNICEF
86 2005 Survey/reported WHO/UNICEF
86 2004 Survey/reported WHO/UNICEF
84 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
82 2001 Survey/reported WHO/UNICEF
64 2000 Survey/reported WHO/UNICEF
97 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
98 2019 Survey/reported WHO/UNICEF
99 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
63 (57 - 72) 2015 Survey/reported EMCDDA, 2017
108 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
45 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
2030
HepB birth dose policy
Yes
Year of birth dose introduction
2000
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
2030
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.8 (0.70 - 1.10) 2015 Modelled Blach et al, 2017
1.02 (0.84 - 1.23) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.83 - 1.23) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.83 - 1.23) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.82 - 1.21) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.21) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.20) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.20) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.20) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.19) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.19) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.19) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.18) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.18) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.18) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.79 - 1.17) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.18) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.18) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.20) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.79 - 1.16) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
36.5 2010 Survey/reported EMCDDA
28.68 2009 Survey/reported EMCDDA
33.5 2008 Survey/reported EMCDDA
38.68 2007 Survey/reported EMCDDA
41.73 2006 Survey/reported EMCDDA
38.8 2005 Survey/reported EMCDDA
44.49 2004 Survey/reported EMCDDA
45.14 2003 Survey/reported EMCDDA
63.96 2002 Survey/reported EMCDDA
44.72 2001 Survey/reported EMCDDA
48.88 2000 Survey/reported EMCDDA
82.2 2016 Survey/reported EMCDDA
83.5 2015 Survey/reported EMCDDA
84.39 2014 Survey/reported EMCDDA
84.3 2013 Survey/reported EMCDDA
83.78 2012 Survey/reported EMCDDA
82.16 2011 Survey/reported EMCDDA
83.18 2010 Survey/reported EMCDDA
83.13 2009 Survey/reported EMCDDA
84.5 2008 Survey/reported EMCDDA
82.3 2007 Survey/reported EMCDDA
84.8 2006 Survey/reported EMCDDA
84.2 2005 Survey/reported EMCDDA
85.1 2004 Survey/reported EMCDDA
39.94 2009 Survey/reported EMCDDA
41 2008 Survey/reported EMCDDA
43.7 2007 Survey/reported EMCDDA
43.21 2006 Survey/reported EMCDDA
45.78 2005 Survey/reported EMCDDA
49.58 2004 Survey/reported EMCDDA
48 2003 Survey/reported EMCDDA
51.3 2002 Survey/reported EMCDDA
50.9 2001 Survey/reported EMCDDA
48.8 2000 Survey/reported EMCDDA
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.25 (0.21 - 0.34) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.2 (0.40 - 2.50) 2017 Survey/reported Rocha, 2017
0.54 (0.20 - 0.90) 2016 Survey/reported Carvalhana SC et al, 2016
1.8 (0.50 - 2.90) 2014 Modelled Gower et al, 2014
0.5 (0.20 - 0.90) 2014 Survey/reported ECDC
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
87.7 (80.50 - 95) 2016 Modelled Degenhardt L et al, 2017
84.3 (80.40 - 87.70) 2013 Survey/reported EMCDDA
81.5 2017 Survey/reported ECDC
Showing out of
Show more
Prisoners
Download
Value (%) Year Type Source
34.4 (26.90 - 42.60) 2008 Survey/reported Marques NM et al, 2011
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
89,000 (74,000 - 120,000) 2015 Modelled Blach et al, 2017
93,742 (77,184 - 114,149) 1990 Modelled IHME, GBD 2019 (accessed 2022)
93,941 (77,614 - 114,124) 1991 Modelled IHME, GBD 2019 (accessed 2022)
94,165 (78,028 - 113,553) 1992 Modelled IHME, GBD 2019 (accessed 2022)
94,479 (78,300 - 113,989) 1993 Modelled IHME, GBD 2019 (accessed 2022)
94,906 (78,401 - 114,403) 1994 Modelled IHME, GBD 2019 (accessed 2022)
95,484 (78,965 - 115,521) 1995 Modelled IHME, GBD 2019 (accessed 2022)
95,985 (79,462 - 115,602) 1996 Modelled IHME, GBD 2019 (accessed 2022)
96,193 (79,409 - 115,992) 1997 Modelled IHME, GBD 2019 (accessed 2022)
96,295 (79,169 - 115,945) 1998 Modelled IHME, GBD 2019 (accessed 2022)
96,401 (78,959 - 116,511) 1999 Modelled IHME, GBD 2019 (accessed 2022)
96,693 (79,237 - 117,247) 2000 Modelled IHME, GBD 2019 (accessed 2022)
97,159 (79,844 - 117,707) 2001 Modelled IHME, GBD 2019 (accessed 2022)
97,528 (80,267 - 117,620) 2002 Modelled IHME, GBD 2019 (accessed 2022)
97,863 (80,594 - 118,084) 2003 Modelled IHME, GBD 2019 (accessed 2022)
98,215 (81,079 - 118,746) 2004 Modelled IHME, GBD 2019 (accessed 2022)
98,635 (81,106 - 119,513) 2005 Modelled IHME, GBD 2019 (accessed 2022)
99,071 (81,597 - 120,188) 2006 Modelled IHME, GBD 2019 (accessed 2022)
99,370 (81,836 - 120,775) 2007 Modelled IHME, GBD 2019 (accessed 2022)
99,624 (81,859 - 121,045) 2008 Modelled IHME, GBD 2019 (accessed 2022)
99,870 (81,920 - 121,620) 2009 Modelled IHME, GBD 2019 (accessed 2022)
100,168 (82,068 - 121,505) 2010 Modelled IHME, GBD 2019 (accessed 2022)
100,476 (82,316 - 121,990) 2011 Modelled IHME, GBD 2019 (accessed 2022)
100,635 (82,982 - 122,270) 2012 Modelled IHME, GBD 2019 (accessed 2022)
100,767 (82,667 - 122,945) 2013 Modelled IHME, GBD 2019 (accessed 2022)
100,916 (82,419 - 123,045) 2014 Modelled IHME, GBD 2019 (accessed 2022)
101,141 (82,588 - 123,537) 2015 Modelled IHME, GBD 2019 (accessed 2022)
101,890 (83,548 - 123,651) 2016 Modelled IHME, GBD 2019 (accessed 2022)
102,743 (84,667 - 124,862) 2017 Modelled IHME, GBD 2019 (accessed 2022)
103,205 (85,176 - 125,138) 2018 Modelled IHME, GBD 2019 (accessed 2022)
102,270 (84,036 - 123,899) 2019 Modelled IHME, GBD 2019 (accessed 2020)
103,292 (84,982 - 124,901) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
5,600 (4,700 - 7,600) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
7.22 (5.74 - 8.81) 2019 Modelled IHME, GBD 2019 (accessed 2020)
6.98 (5.33 - 9.24) 1990 Modelled IHME, GBD 2019 (accessed 2022)
7.12 (5.48 - 9.43) 1991 Modelled IHME, GBD 2019 (accessed 2022)
7.1 (5.50 - 9.32) 1992 Modelled IHME, GBD 2019 (accessed 2022)
7.12 (5.51 - 9.27) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6.85 (5.30 - 8.83) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6.91 (5.37 - 8.90) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6.98 (5.47 - 8.90) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6.86 (5.38 - 8.70) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6.79 (5.33 - 8.57) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6.59 (5.21 - 8.29) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6.72 (5.29 - 8.47) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6.41 (5.10 - 8.09) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6.58 (5.25 - 8.28) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6.38 (5.09 - 8.04) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6.26 (5 - 7.86) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6.27 (5 - 7.84) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6.27 (5.01 - 7.83) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6.36 (5.09 - 7.93) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6.42 (5.17 - 7.99) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6.54 (5.30 - 8.13) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6.63 (5.37 - 8.21) 2010 Modelled IHME, GBD 2019 (accessed 2022)
6.7 (5.43 - 8.24) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6.77 (5.49 - 8.32) 2012 Modelled IHME, GBD 2019 (accessed 2022)
6.83 (5.55 - 8.35) 2013 Modelled IHME, GBD 2019 (accessed 2022)
6.85 (5.56 - 8.36) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6.86 (5.51 - 8.40) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7.05 (5.67 - 8.62) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7.12 (5.73 - 8.77) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7.15 (5.73 - 8.75) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7.22 (5.74 - 8.81) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
661 2016 Modelled WHO
769 (611 - 938) 2019 Modelled IHME, GBD 2019 (accessed 2022)
769 (611 - 939) 2019 Modelled IHME, GBD 2019 (accessed 2020)
764 (612 - 934) 2018 Modelled IHME, GBD 2019 (accessed 2022)
762 (613 - 939) 2017 Modelled IHME, GBD 2019 (accessed 2022)
756 (608 - 924) 2016 Modelled IHME, GBD 2019 (accessed 2022)
737 (592 - 903) 2015 Modelled IHME, GBD 2019 (accessed 2022)
737 (598 - 899) 2014 Modelled IHME, GBD 2019 (accessed 2022)
736 (598 - 900) 2013 Modelled IHME, GBD 2019 (accessed 2022)
730 (592 - 897) 2012 Modelled IHME, GBD 2019 (accessed 2022)
723 (586 - 889) 2011 Modelled IHME, GBD 2019 (accessed 2022)
716 (580 - 887) 2010 Modelled IHME, GBD 2019 (accessed 2022)
705 (572 - 878) 2009 Modelled IHME, GBD 2019 (accessed 2022)
693 (558 - 862) 2008 Modelled IHME, GBD 2019 (accessed 2022)
685 (548 - 854) 2007 Modelled IHME, GBD 2019 (accessed 2022)
675 (539 - 843) 2006 Modelled IHME, GBD 2019 (accessed 2022)
673 (537 - 842) 2005 Modelled IHME, GBD 2019 (accessed 2022)
670 (535 - 842) 2004 Modelled IHME, GBD 2019 (accessed 2022)
681 (543 - 859) 2003 Modelled IHME, GBD 2019 (accessed 2022)
683 (543 - 861) 2002 Modelled IHME, GBD 2019 (accessed 2022)
698 (557 - 877) 2001 Modelled IHME, GBD 2019 (accessed 2022)
695 (549 - 874) 2000 Modelled IHME, GBD 2019 (accessed 2022)
705 (555 - 888) 1999 Modelled IHME, GBD 2019 (accessed 2022)
708 (555 - 893) 1998 Modelled IHME, GBD 2019 (accessed 2022)
711 (558 - 902) 1997 Modelled IHME, GBD 2019 (accessed 2022)
720 (564 - 918) 1996 Modelled IHME, GBD 2019 (accessed 2022)
709 (551 - 913) 1995 Modelled IHME, GBD 2019 (accessed 2022)
699 (542 - 902) 1994 Modelled IHME, GBD 2019 (accessed 2022)
725 (561 - 944) 1993 Modelled IHME, GBD 2019 (accessed 2022)
721 (558 - 946) 1992 Modelled IHME, GBD 2019 (accessed 2022)
722 (556 - 956) 1991 Modelled IHME, GBD 2019 (accessed 2022)
708 (540 - 937) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
10 (8 - 13) 1990 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1991 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 1992 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 1993 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 1994 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 1995 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 22) 1996 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 23) 1997 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 24) 1998 Modelled IHME, GBD 2019 (accessed 2022)
20 (14 - 25) 1999 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 26) 2000 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 28) 2001 Modelled IHME, GBD 2019 (accessed 2022)
21 (15 - 27) 2002 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 29) 2004 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 27) 2003 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 30) 2005 Modelled IHME, GBD 2019 (accessed 2022)
25 (18 - 32) 2006 Modelled IHME, GBD 2019 (accessed 2022)
26 (19 - 32) 2007 Modelled IHME, GBD 2019 (accessed 2022)
27 (20 - 34) 2008 Modelled IHME, GBD 2019 (accessed 2022)
28 (21 - 36) 2009 Modelled IHME, GBD 2019 (accessed 2022)
30 (23 - 38) 2010 Modelled IHME, GBD 2019 (accessed 2022)
32 (24 - 40) 2011 Modelled IHME, GBD 2019 (accessed 2022)
35 (26 - 44) 2013 Modelled IHME, GBD 2019 (accessed 2022)
33 (25 - 42) 2012 Modelled IHME, GBD 2019 (accessed 2022)
36 (27 - 45) 2014 Modelled IHME, GBD 2019 (accessed 2022)
36 (27 - 46) 2015 Modelled IHME, GBD 2019 (accessed 2022)
37 (28 - 46) 2016 Modelled IHME, GBD 2019 (accessed 2022)
36 (27 - 45) 2017 Modelled IHME, GBD 2019 (accessed 2022)
35 (26 - 45) 2018 Modelled IHME, GBD 2019 (accessed 2022)
35 (26 - 44) 2019 Modelled IHME, GBD 2019 (accessed 2022)
39 (29 - 48) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
2,732 2017 Survey/reported ECDC, 2019
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
63 (57 - 72) 2015 Survey/reported EMCDDA, 2017
108 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
45 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
2030
HepB birth dose policy
Yes
Year of birth dose introduction
2000
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
2030
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Overview

HBV elimination goal
2030
HCV elimination goal
2030

Hepatitis related deaths (national)

Modelled

HBV
258
2019
(199 - 333)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
769
2019
(611 - 938)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
97 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
108
2017
ECDC
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources